Basel, Basel, Switzerland
I am a senior finance executive with 20+ years of experience in the pharmaceutical and life sciences industries, leading financial strategy, P&L management, and business transformation across EMEA and emerging markets. I specialize in FP&A, risk management, contract negociations, aligning financial operations with corporate growth objectives. Throughout my career, I have successfully led large-scale finance transformations, optimized revenue streams, and strengthened financial governance in highly regulated environments. I have worked closely with CEOs, commercial teams, to develop scalable financial frameworks, and implement enterprise financial systems (SAP S4 HANA, Hyperion, Concur). I am passionate about driving sustainable business growth through financial innovation, data-driven decision-making, and commercial partnerships. My approach combines strategic financial planning, risk mitigation, and operational efficiency, ensuring long-term profitability.
-Led $500M+ P&L, overseeing financial strategy, FP&A, and M&A across global markets. -Optimized cash flow by $10M, reducing AR backlog by 90%. -Developed a 5-year strategic growth plan, driving $150M in projected revenue. -Implemented SAP S4 HANA and Concur, increasing finance efficiency by 50%.
-CFO for a $560M regional business spanning 11 countries, leading five local CFOs and aligning financial strategy with business expansion & go-to-market models. -Led FP&A restructuring, centralizing functions into a Shared Service Center, improving scalability and forecasting accuracy. -Redesigned large account incentive structures, generating $15M in incremental revenue through strategic sales partnerships.
-Managed largest commercial unit in Europe ($500M revenue), ensuring alignment with regulatory & commercial objectives. -Achieved bad debts under 1% by implementing tight credit controls (collaterals & guarantees for high-risk customers). -Preserved profit contribution in USD terms during the 2014 financial crisis, despite a 50% currency devaluation and 15% inflation, through cash flow hedging and price increases. -Implemented Russia’s first weather risk management program, mitigating financial risk for leading agro-industrial holding companies.
-Restructured commercial terms & supply chain to align with Russia’s Pharma 2020 framework, accelerating HIV drug inclusion in state reimbursement programs and driving $8M net sales growth. -Negotiated a $25M distribution deal for the BMS UPSA portfolio in Russia. -Implemented SAP (general accounting, OTC, purchasing) & Concur (T&E expenses), improving financial control & compliance.
Analysis, design, implementation, and training of Hyperion as a new financial planning tool. Worldwide scope.